Journal of Bone and Mineral Metabolism

, Volume 37, Issue 1, pp 125–133 | Cite as

Comparison of clinical, biochemical and histomorphometric analysis of bone biopsies in dialysis patients with and without fractures

  • Melissa F. P. Santos
  • Mariel J. Hernández
  • Ivone B. de Oliveira
  • Flávia R. Siqueira
  • Wagner V. Dominguez
  • Luciene M. dos Reis
  • Aluizio B. Carvalho
  • Rosa M. A. Moysés
  • Vanda JorgettiEmail author
Original Article


Chronic kidney disease-mineral bone disorders (CKD-MBD) are associated with increased risk of fracture. Studies report about 3% of fractures in CKD patients, and these occur earlier than in the general population, namely 16 and 13 years earlier for men and women, respectively. Better understanding of the pathophysiology of fractures would probably contribute to new therapeutic approaches. This study aimed to evaluate report of long bone fractures from a bone biopsies bank from patients on hemodialysis and compare clinical and biochemical characteristics, as well as the results of the histomorphometric analysis of trabecular and cortical bone of these patients with a control group (without fractures), paired for age, gender, and time on hemodialysis. Bone proteins (SOST, DMP1 and MEPE) were evaluated by immunohistochemistry. Seventeen patients with fracture and controls were studied. Fracture prevalence was 0.82/1000 patients/year. Serum phosphorus levels were significantly lower in the fracture group. Histomorphometric analysis revealed that all the patients had high turnover disease, and the fracture group had smaller volume and trabecular thickness, greater osteoid surface, smaller eroded surface, smaller mineralizing surface, formation rate and longer mineralization lag time when compared to controls; the DMP1 expression in the cortical bone was smaller and the SOST in the trabecular bone was higher in fractured patients. As conclusion, we found low prevalence of fractures. Both groups had high turnover disease, but the fractured ones presented more impaired bone microarchitecture, as well as lower formation and greater mineralization defect. Bone proteins expression correlated with parameters involved in bone remodeling.


Fracture CKD-MBD Bone turnover Histomorphometry Immunohistochemistry 



This study was presented, in part, at the 2017 World Congress of Nephrology in Mexico City, Mexico. The results presented in this paper have not been published previously in whole or part, except in abstract format. The authors thank Rosimeire A. B. Costa for the technical support.

Compliance with ethical standards

Conflict of interest

Rosa M. A. Moysés, Vanda Jorgetti and Aluizio B. Carvalho have received lecture fees and are consultant to Sanofi, Abbott do Brasil, and Amgen. All other authors have no conflict of interest.


  1. 1.
    Clarke B (2008) Normal bone anatomy and physiology. Clin J Am Soc Nephrol 3:S131–S139CrossRefGoogle Scholar
  2. 2.
    Jamal SA (2010) Bone mass measurements in men and women with chronic kidney disease. Curr Opin Nephrol Hypertens 19:343–348CrossRefGoogle Scholar
  3. 3.
    Cooper C, Campion G, Melton LJ 3rd (1992) Hip fractures in the elderly: a world-wide projection. Osteoporos Int 2:285–289CrossRefGoogle Scholar
  4. 4.
    Burge R, Dawson-Hughes B, Solomon DH, Wong JB, King A, Tosteson A (2007) Incidence and economic burden of osteoporosis-related fractures in United States, 2005–2025. J Bone Miner Res 22:465–475CrossRefGoogle Scholar
  5. 5.
    Coco M, Rush H (2000) Increased incidence of hip fracture in dialysis patients with low serum parathyroid hormone. Am J Kidney Dis 36:1115–1121CrossRefGoogle Scholar
  6. 6.
    De Oliveira RA, Barreto FC, Mendes M, dos Reis LM, Castro JH, Britto ZM, Marques ID, Carvalho AB, Moysés RM, Jorgetti V (2015) Peritoneal dialysis per se is a risk factor for sclerostin-associated adynamic bone disease. Kidney Int 87:1039–1045CrossRefGoogle Scholar
  7. 7.
    Gomes SA, dos Reis LM, de Oliveira IB, Noronha IL, Jorgetti V, Heilberg IP (2008) Usefulness of a quick decalcification of bone sections embedded in methyl methacrylate: an improved method for immunohistochemistry. J Bone Miner Metab 26:110–113CrossRefGoogle Scholar
  8. 8.
    Graciolli FG, Neves KR, Barreto F, Barreto DV, dos Reis LM, Canziani ME, Sabbagh Y, Carvalho AB, Jorgetti V, Elias RM, Schiavi S, Moyses RMA (2017) The complexity of chronic disease-mineral and bone across stages of chronic kidney disease. Kidney Int 91:1436–1446CrossRefGoogle Scholar
  9. 9.
    Dempster DW, Compston JE, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker RR, Parfitt AM (2013) Standardized nomenclature, symbols, and units for Bone Histomorphometry: a 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 28:2–17CrossRefGoogle Scholar
  10. 10.
    Dos Reis LM, Batalha JR, Muñoz DR, Borelli A, Correa PH, Carvalho AB, Jorgetti V (2007) Brazilian normal static bone histomorphometry: effects of age, sex and race. J Bone Miner Metab 25:400–406CrossRefGoogle Scholar
  11. 11.
    Rehman MTA, Hoyland JA, Denton J, Freemont AJ (1994) Age related histomorphometric changes in bone in normal British men and women. J Clin Pathol 47:529–534CrossRefGoogle Scholar
  12. 12.
    Moe S, Drüeke T, Cunningham J, Goodman W, Martin K, Olgaard K, Ott S, Sprague S, Lameire N, Eknoyan G (2006) Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 69:1945–1953CrossRefGoogle Scholar
  13. 13.
    Tentori F, McCullough K, Kilpatrick RD, Bradbury BD, Robinson BM, Kerr PG, Pisoni RL (2014) High rates of death and hospitalization follow bone fracture among hemodialysis patients. Kidney Int 85:166–173CrossRefGoogle Scholar
  14. 14.
    Miller PD (2016) Underdiagnoses and undertreatment of osteoporosis: the battle to be won. J Clin Endocrinol Metab 101:852–859CrossRefGoogle Scholar
  15. 15.
    Goldenstein PT, Elias RM, Pires de Freitas do Carmo L, Coelho FO, Magalhães LP, Antunes GL, Custódio MR, Montenegro FL, Titan SM, Jorgetti V, Moysés RM (2013) Parathyroidectomy improves survival in patients with severe hyperparathyroidism: a comparative study. PLoS One 8:e68870CrossRefGoogle Scholar
  16. 16.
    Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Update Work Group (2017) KDIGO 2017 clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease–mineral and bone disorder (CKD-MBD). Kidney Int Suppl 7:1–59CrossRefGoogle Scholar
  17. 17.
    Miller PD (2014) Chronic kidney disease and osteoporosis: evaluation and management. Bonekey Rep 3:542CrossRefGoogle Scholar
  18. 18.
    Chappard D, Bizot D, Mabilleau G, Hubert L (2016) Aluminum and bone: review of new circumstances associated with Al3+ deposition in the calcified matrix of bone. Morphologie 100:95–105CrossRefGoogle Scholar
  19. 19.
    Zheng CM, Zheng JQ, Wu CC, Lu CL, Shyu JF, Yung-Ho H, Wu MY, Chiu IJ, Wang YH, Lin YF, Lu KC (2016) Bone loss in chronic kidney disease: quantity or Quality? Bone 6:57–70CrossRefGoogle Scholar
  20. 20.
    McNerny EMB, Nickolas TL (2017) Bone quality in chronic kidney disease: definitions and diagnosis. Curr Osteoporos Rep 15:207–213CrossRefGoogle Scholar
  21. 21.
    Barger-Lux MJ, Recker RR (2002) Bone microstructure in osteoporosis: transilial biopsy and histomorphometry. Top Magn Reson Imaging 13:297–306CrossRefGoogle Scholar
  22. 22.
    Hanudel MR, Froch L, Gales B, Jüppner H, Salusky IB (2017) Fractures and osteomalacia in a patient treated with frequent home hemodialysis. Am J Kidney Dis 70:445–448CrossRefGoogle Scholar
  23. 23.
    Pereira RC, Juppner H, Azucena-Serrano CE, Yadin O, Salusky IB, Wesseling-Perry K (2009) Patterns of FGF-23, DMP1, and MEPE expression in patients with chronic kidney disease. Bone 45:1161–1168CrossRefGoogle Scholar
  24. 24.
    Suzuki S, Haruyama N, Nishimura F, Kulkarni AB (2012) Dentin sialophosphoprotein and dentin matrix protein-1: two highly phosphorylated proteins in mineralized tissues. Arch Oral Biol 57:1165–1175CrossRefGoogle Scholar
  25. 25.
    Winkler DG, Sutherland MK, Georghegan JC, Yu C, Hayes T, Skonier JE, Shpektor D, Jonas M, Kovacevich BR, Staehling-Hampton K, Appleby M, Brunkow ME, Latham JA (2003) Osteocyte control of bone formation via sclerostin, a novel BMP antagonist. EMBO J. 22:6267–6276CrossRefGoogle Scholar
  26. 26.
    Addison WN, Masica DL, Gray JJ, McKee MD (2010) Phosphorylation-dependent inhibition of mineralization by osteopontin ASARM peptides is regulated by PHEX cleavage. J Bone Miner Res 25:695–705CrossRefGoogle Scholar

Copyright information

© The Japanese Society for Bone and Mineral Research and Springer Japan KK, part of Springer Nature 2018

Authors and Affiliations

  • Melissa F. P. Santos
    • 1
  • Mariel J. Hernández
    • 2
  • Ivone B. de Oliveira
    • 1
  • Flávia R. Siqueira
    • 1
  • Wagner V. Dominguez
    • 1
  • Luciene M. dos Reis
    • 1
  • Aluizio B. Carvalho
    • 3
  • Rosa M. A. Moysés
    • 1
    • 4
  • Vanda Jorgetti
    • 1
    Email author
  1. 1.Nephrology Division, Medical SchoolUniversity of São PauloSão PauloBrazil
  2. 2.Servicio de Nefrología y Trasplante Renal, Hospital Universitario de CaracasUniversidad Central de VenezuelaCaracasVenezuela
  3. 3.Nephrology DivisionUniversidade Federal de São PauloSão PauloBrazil
  4. 4.Medicine Master Degree ProgramUniversidade Nove de Julho (UNINOVE)São PauloBrazil

Personalised recommendations